Kronauge JF[au] - Search Results

Year	Number of Results
1982	1
1985	1
1987	2
1988	1
1989	1
1990	3
1991	1
1992	6
1993	4
1994	4
1995	3
1997	1
1998	4
2002	1
2010	2
2014	1
2017	1
2022	0

1

Phase-1 clinical trial results of high-specific-activity carrier-free 123I-iobenguane.

Chin BB, Kronauge JF, Femia FJ, Chen J, Maresca KP, Hillier S, Petry NA, James OG, Oldan JD, Armor T, Stubbs JB, Stabin MG, Babich JW. Chin BB, et al. Among authors: kronauge jf. J Nucl Med. 2014 May;55(5):765-71. doi: 10.2967/jnumed.113.124057. Epub 2014 Mar 13. J Nucl Med. 2014. PMID: 24627436 Free article. Clinical Trial.

2

A phase one, single-dose, open-label, clinical safety and PET/MR imaging study of ⁶⁸Ga-DOTATOC in healthy volunteers.

Esfahani SA, Salcedo S, Heidari P, Catalano OA, Pauplis R, Hesterman J, Kronauge JF, Mahmood U. Esfahani SA, et al. Among authors: kronauge jf. Am J Nucl Med Mol Imaging. 2017 Apr 15;7(2):53-62. eCollection 2017. Am J Nucl Med Mol Imaging. 2017. PMID: 28533937 Free PMC article.

3

Characterization of P-glycoprotein transport and inhibition in vivo.

Barbarics E, Kronauge JF, Cohen D, Davison A, Jones AG, Croop JM. Barbarics E, et al. Among authors: kronauge jf. Cancer Res. 1998 Jan 15;58(2):276-82. Cancer Res. 1998. PMID: 9443405

4

Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution.

Barrett JA, Joyal JL, Hillier SM, Maresca KP, Femia FJ, Kronauge JF, Boyd M, Mairs RJ, Babich JW. Barrett JA, et al. Among authors: kronauge jf. Cancer Biother Radiopharm. 2010 Jun;25(3):299-308. doi: 10.1089/cbr.2009.0695. Cancer Biother Radiopharm. 2010. PMID: 20578835 Free article.

5

Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.

Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Piwnica-Worms D, et al. Among authors: kronauge jf. Cancer Res. 1993 Mar 1;53(5):977-84. Cancer Res. 1993. PMID: 8094997

6

Synthesis and biodistribution of a Lipophilic 64Cu-labeled monocationic Copper(II) complex.

Packard AB, Kronauge JF, Barbarics E, Kiani S, Treves ST. Packard AB, et al. Among authors: kronauge jf. Nucl Med Biol. 2002 Apr;29(3):289-94. doi: 10.1016/s0969-8051(02)00285-8. Nucl Med Biol. 2002. PMID: 11929697

7

Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.

Piwnica-Worms D, Rao VV, Kronauge JF, Croop JM. Piwnica-Worms D, et al. Among authors: kronauge jf. Biochemistry. 1995 Sep 26;34(38):12210-20. doi: 10.1021/bi00038a015. Biochemistry. 1995. PMID: 7547962

8

Novel hexakis(areneisonitrile)technetium(I) complexes as radioligands targeted to the multidrug resistance P-glycoprotein.

Herman LW, Sharma V, Kronauge JF, Barbarics E, Herman LA, Piwnica-Worms D. Herman LW, et al. Among authors: kronauge jf. J Med Chem. 1995 Jul 21;38(15):2955-63. doi: 10.1021/jm00015a018. J Med Chem. 1995. PMID: 7636856

9

Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts.

Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, Piwnica-Worms D. Carvalho PA, et al. Among authors: kronauge jf. J Nucl Med. 1992 Aug;33(8):1516-22. J Nucl Med. 1992. PMID: 1634944 Free article.

10

Divergent kinetics of 201Tl and 99mTc-SESTAMIBI in cultured chick ventricular myocytes during ATP depletion.

Piwnica-Worms D, Chiu ML, Kronauge JF. Piwnica-Worms D, et al. Among authors: kronauge jf. Circulation. 1992 Apr;85(4):1531-41. doi: 10.1161/01.cir.85.4.1531. Circulation. 1992. PMID: 1313342

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results